GeNose C19: AI-Powered Rapid COVID-19 Breathalyzer Screening System
Participated in the development, field deployment, and public demonstration of GeNose C19, an electronic nose (e-nose) diagnostic device developed by Universitas Gadjah Mada (UGM) that combines gas sensor arrays with artificial intelligence to detect COVID-19 via human breath in under two minutes.



Project Overview
GeNose C19 is a rapid, non-invasive COVID-19 screening device developed by a multidisciplinary research team at Universitas Gadjah Mada (UGM). Designed as a fast and cost-effective alternative to conventional swab tests, the system analyzes Volatile Organic Compounds (VOCs) present in human breath to detect SARS-CoV-2 infection in less than two minutes.
How It Works: Electronic Nose + AI
Unlike biological tests that look for viral RNA or antigens, GeNose C19 mimics the human olfactory system using an array of metal-oxide semiconductor (MOS) gas sensors paired with machine learning algorithms.
- Breath Sampling: The subject exhales into a specialized, single-use medical-grade air bag equipped with a HEPA filter to prevent cross-contamination.
- VOC Sensing: The breath sample is drawn into the sensing chamber, where the gas sensor array reacts to specific VOC patterns exhaled by infected individuals, generating multi-channel time-series voltage responses ().
- Feature Extraction & Classification: Raw sensor signals undergo baseline correction and normalization before being fed into a trained machine learning classification model to distinguish positive and negative VOC profiles in real time.
My Role & Field Contributions
During my involvement with the GeNose C19 development and deployment team, I contributed across data science, technical engineering, and real-world operational rollouts:
- Data Analysis & Prediction Model Development: Analyzed multi-channel gas sensor time-series data, performed signal preprocessing and feature extraction, and developed and evaluated machine learning classification models to accurately predict COVID-19 status from breath VOC profiles.
- System Testing & Calibration: Assisted in hardware-software integration, sensor response verification, and data acquisition workflows to maintain consistent detection accuracy across units.
- Field Deployment & Operator Training: Conducted on-site demonstrations, system setups, and operator training sessions for healthcare staff and institutional partners during public screening rollouts.
- Live Data Monitoring: Supported real-time diagnostic software operation and troubleshooting during high-throughput screening trials.
Media & Public Coverage
GeNose C19 received widespread national recognition and was deployed across major Indonesian transportation hubs (such as railway stations and airports), hospitals, and public institutions following its official distribution permit from the Ministry of Health.